title: Ovarian Cancer Survival and Chemotherapy Dosing, Body Mass Index, and Body Surface Area : Are We There Yet?
authors.affiliation: Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.
authors.forename: S Percy
authors.initials: SP
authors.lastname: Ivy
authors.affiliation: Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania3Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania.
authors.forename: Jan H
authors.initials: JH
authors.lastname: Beumer
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D015992:Body Mass Index; D002945:Cisplatin / Q000008:administration & dosage*; D054796:Drug Dosage Calculations; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000188:drug therapy*; D009765:Obesity / Q000150:complications*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage*
chemical_list: D017239:Paclitaxel; D002945:Cisplatin